Compare Ticagrelor vs Clopidogrel on the Reduction of Arterial Stiffness and Wave Reflectionsin Patients With CAD.

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.

Also called NCT02071212

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
  • AstraZeneca Registry lists this organization as a collaborator
Registry
  • NCT NCT02071212
Other papers using this trial's data
  • Effect of Ticagrelor Versus Clopidogrel on Aortic Stiffness in Patients With Coronary Artery Disease Journal of the American Heart Association, 2019-06-18 DOI, PubMed 31165663, PMC6645640 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Greece (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02071212. Randomized; single masking; primary purpose treatment. Start 2014-02 (registry gives no type); primary completion 2018-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Compare Ticagrelor vs Clopidogrel on the Reduction of Arterial Stiffness and Wave Reflectionsin Patients With CAD.
Acronym
NOVELTY
Intervention (Drug)
Ticagrelor
Lead sponsor
Hellenic Cardiovascular Research Society (class: other)
Collaborator
AstraZeneca (class: industry)

Record details

Record id
cardio:ct-nct02071212
Content hash
6f65d1a757d2c8d2860be2bd3b80f6b5f2667725eaa5f7f94a074417d2d92889